Ryman Healthcare Limited (NZSE:RYM) shareholders should be happy to see the share price up 14% in the last month. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. Indeed ...
The projected fair value for Ryman Healthcare is NZ$5.74 based on 2 Stage Free Cash Flow to Equity Ryman Healthcare is estimated to be 47% undervalued based on current share price of NZ$3.05 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback